October 17, 2019
  • October 17, 2019
Breaking News

Tag Archives

FDA granted approval Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for Soliris

by on June 28, 2019 0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been granted approval by the Food and Drug Administration for Soliris. Soliris (eculizumab) is an injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), a Healthcare sector firm, traded 1.01 Million shares in last trading session with closing price of $126.11 per... Read More